Nautilus Biotechnology, Inc.

Rachunek Zysków i Strat kwartalnie


Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
Rok finansowy 2018 2019 2019 2019 2019 2020 2020 2020 2020 2021 2021 2021 2021 2022 2022 2022 2022 2023 2023 2023 2023 2024 2024 2024 2024
Data 2018-12-31 2019-03-31 2019-06-30 2019-09-30 2019-12-31 2020-03-31 2020-06-30 2020-09-30 2020-12-31 2021-03-31 2021-06-30 2021-09-30 2021-12-31 2022-03-31 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31 2024-06-30 2024-09-30 2024-12-31
Kwartał Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
Przychód (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8 0 0 0 0
Przychód Δ kw/kw 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% inf% 0.0% 0.0% 0.0% <span style="color:red">-100.00%</span>
Marża brutto 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% <span style="color:red">-inf%</span> <span style="color:red">-inf%</span> <span style="color:red">-inf%</span> <span style="color:red">-inf%</span> <span style="color:red">-inf%</span> 0.0% <span style="color:red">-inf%</span> <span style="color:red">-inf%</span> <span style="color:red">-inf%</span> <span style="color:red">-inf%</span> 80.6% <span style="color:red">-inf%</span> <span style="color:red">-inf%</span> <span style="color:red">-inf%</span> 0.0%
Koszty i Wydatki (mln) 112 0 0 0 0 4 3 4 5 8 11 15 17 16 15 16 16 18 19 19 20 22 21 19 20
EBIT (mln) -112 -0 -0 -0 -0 -4 -3 -4 -5 -8 -11 -15 -17 -16 -15 -16 -17 -18 -16 -16 -17 -22 -21 -19 0
EBIT Δ kw/kw 31350.3% 96.3% 97.4% 95.6% 93.3% 51.0% 68.2% 72.4% 68.1% 47.5% 30.9% 7.9% 3.1% 11.3% 2.1% 0.4% 1.2% 16.4% 24.0% 16.9% 0.0% 0.0% 0.0% 0.0% 100.0%
EBIT (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% <span style="color:red">-207.31%</span> 0.0% 0.0% 0.0% nan
Przychody fiansowe (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 3 3 3 3 3 3 3 3 2
Koszty finansowe (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 3 0 0 0 0
Amortyzacja (mln) 738 1 1 1 1 0 0 1 1 1 0 0 0 1 1 1 1 1 1 2 2 2 2 2 2
EBITDA (mln) 627 1 1 1 0 -3 -3 -4 -5 -8 -10 -14 -17 -15 -14 -16 -16 -18 -19 -19 -19 -21 -20 -15 -18
EBITDA(%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% <span style="color:red">-224.20%</span> 0.0% 0.0% 0.0% nan
NOPLAT (mln) 627 1 1 1 0 -3 -3 -4 -5 -8 -11 -15 -17 -16 -15 -14 -13 -15 -16 -16 -17 -19 -18 -16 -18
Podatek (mln) 0 1 1 1 1 1 -0 0 0 0 0 -1 1 -0 -1 -2 3 -3 -3 3 -3 2 0 0 0
Zysk Netto (mln) 627 1 1 1 0 -3 -3 -4 -5 -8 -11 -15 -17 -16 -14 -14 -16 -12 -16 -16 -17 -19 -18 -16 -18
Zysk netto Δ kw/kw 0.0% 0.0% 0.0% 0.0% <span style="color:red">-99.94%</span> <span style="color:red">-554.93%</span> <span style="color:red">-491.41%</span> <span style="color:red">-744.52%</span> <span style="color:red">-1488.36%</span> 157.2% 219.3% 264.6% 211.8% 84.4% 29.8% <span style="color:red">-3.04%</span> <span style="color:red">-2.36%</span> <span style="color:red">-23.44%</span> 13.7% 12.9% 4.5% 57.8% 13.9% 3.6% 3.3%
Zysk netto (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% <span style="color:red">-207.31%</span> 0.0% 0.0% 0.0% nan
EPS 87.18 0.1 0.12 0.0859 0.0536 -0.45 -0.12 -0.13 -0.17 -0.0678 -0.0863 -0.12 -0.13 -0.12 -0.11 -0.11 -0.13 -0.0953 -0.13 -0.13 -0.14 -0.15 -0.14 -0.13 -0.14
EPS (rozwodnione) 87.18 0.1 0.12 0.0859 0.0536 -0.45 -0.12 -0.13 -0.17 -0.0678 -0.0863 -0.12 -0.13 -0.12 -0.11 -0.11 -0.13 -0.0953 -0.13 -0.13 -0.14 -0.15 -0.14 -0.13 -0.14
Ilośc akcji (mln) 7 7 7 7 7 7 28 30 32 124 124 124 124 124 124 125 125 125 125 125 125 125 125 125 126
Ważona ilośc akcji (mln) 7 7 7 7 7 7 28 30 32 124 124 124 124 124 124 125 125 125 125 125 125 125 125 125 126
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD